Download
https://www.ndtvprofit.com/research-reports/pharma-q3-results-preview-positive-attributes-to-aid-in-revenue-growth-gross-margins-axis-securities?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
We expect the pharma universe under our coverage to report healthy aggregate revenue/Ebitda/PAT growth of 7.4%/9.5%/9.1% YoY.
Share